Timothy M. Schmidt, MD, discusses the promise of bispecific antibodies in patients with multiple myeloma.
Timothy M. Schmidt, MD
Advertisement
Articles by Timothy M. Schmidt, MD
Timothy M. Schmidt, MD, discusses the safety and efficacy of teclistamab in patients with multiple myeloma.
Timothy M. Schmidt, MD, discusses the clinical implications of AMG 420 in multiple myeloma.
Timothy M. Schmidt, MD, discusses the utilization of bispecific antibodies in myeloma.
Advertisement
Latest Updated Articles
Dr. Schmidt on the Safety and Efficacy of Teclistamab in Multiple MyelomaPublished: February 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5